Skip to content

ChromaCode

4 viewers · 30d

Total raised

$3.8M

1 filing since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.8M
ROUNDS
1
INVESTORS
4
FOUNDED
N/A
HQ
Carlsbad, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
4

AI overview

Updated

ChromaCode, Inc. is a biotechnology firm focused on revolutionizing diagnostic testing through its advanced PCR multiplexing technology solutions, enhancing efficiency and scalability in biomarker detection. By integrating cloud computing with traditional PCR methods, ChromaCode provides healthcare and research institutions with innovative approaches to diagnostic problem-solving.

What sets it apart

ChromaCode stands out by blending traditional PCR testing with modern cloud computing, creating an accessible, hardware-free, and highly scalable solution.

Funding history

1 round
EquityJan 30, 2025
Form D
+$3.8M$3.8M total

Latest SEC filings

via EDGAR · CIK 0001704675
Form D · Jan 30, 2025View on EDGAR

Products

1 tracked

HDPCRTM Technology

Diagnostic Technology

HDPCRTM Technology is ChromaCode's flagship product, a sophisticated diagnostic tool that markedly enhances traditional PCR testing. By integrating with the ChromaCode Cloud, it offers users an automated and streamlined testing experience.

  • Less than 24-hour turnaround time
  • Minimal hands-on requirements
  • Automated result interpretation via cloud-based computing
  • No need for hardware or software installation

Links

WebsiteSEC EDGAR filings